EndoSonics wins clearance for Trak Back

Article

Intravascular ultrasound developer EndoSonics has received Food and Drug Administration clearance for its disposable pull back device, Trak Back. The device allows users to control EndoSonics’ intravascular ultrasound (IVUS) imaging catheters, thus

Intravascular ultrasound developer EndoSonics has received Food and Drug Administration clearance for its disposable pull back device, Trak Back. The device allows users to control EndoSonics’ intravascular ultrasound (IVUS) imaging catheters, thus facilitating both 3-D-like images and cross-sectional displays. Trak Back was designed for use with EndoSonics’s Oracle ultrasound systems and Visions Five-64 series of ultrasound catheters.

The device is automated, which the Rancho Cordova, CA, company believes will make it easier to use than competitive IVUS products that are mechanical. Trak Back is part of EndoSonics’s strategy to provide its customers with IVUS-guided stenting products by combining its catheters with therapeutic devices. EndoSonics expects to begin shipping Trak Back by the end of the third quarter 1999.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.